News

Telemedicine via WhatsApp improves STEMI care in Tamil Nadu, India, linking hub and spoke hospitals for better outcomes.
The following is a summary of “Visual coronary artery calcification score to predict significant coronary artery stenosis in ...
The following is a summary of “Association of Early Noninvasive Cardiac Stress Testing With Acute Myocardial Infarction and ...
The effectiveness of rivaroxaban, a direct oral anticoagulant, in resolving acute left ventricular thrombus in patients with ST-segment elevation myocardial infarction (STEMI) was similar to that of ...
Cuero Regional Hospital, in collaboration with DeTar Healthcare System, recently conducted a STEMI (ST-Elevation Myocardial ...
In this parallel design, randomized trial, intensive treatment of systolic blood pressure (SBP) resulted in a lower incidence ...
In-hospital mortality in patients with AMI can be predicted with a risk-standardized model that includes patient factors, such as age and cardiogenic shock.
The MACE risk associated with initiating ustekinumab is comparable to that of adalimumab, etanercept, and secukinumab in patients with PsO or PsA.
Aspire Biopharma (ASBP) announced initiation of its Phase 1 single- center clinical study of its lead therapeutic candidate, an oral ...
About Aspire Biopharma, Inc. Headquartered in Humacao, Puerto Rico, Aspire Biopharma has developed a disruptive technology through a Novel Soluble Formulation which addresses emergencies, drug ...
This difficult patient pushes clinical staff to their limits — but his quiet, unnoticed decline exposes critical issues in ...
Eli Lilly & Co. has disclosed new calcium/calmodulin-dependent 3’,5’-cyclic nucleotide phosphodiesterase 1 (PDE1) inhibitors reported to be useful for the treatment of chronic kidney disease, ...